Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Accenture
Deloitte
Colorcon
Baxter
Cerilliant
Fuji
Novartis
Mallinckrodt
QuintilesIMS

Generated: August 22, 2017

DrugPatentWatch Database Preview

TERRAMYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Terramycin, and when can generic versions of Terramycin launch?

Terramycin is a drug marketed by Pfizer and is included in eight NDAs.

The generic ingredient in TERRAMYCIN is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.

Summary for Tradename: TERRAMYCIN

Patents:0
Applicants:1
NDAs:8
Bulk Api Vendors: see list51
Patent Applications: see list5,317
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TERRAMYCIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TERRAMYCIN
lidocaine hydrochloride; oxytetracycline
INJECTABLE;INJECTION060567-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline
TABLET;ORAL050287-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline hydrochloride
CAPSULE;ORAL050286-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline calcium
SYRUP;ORAL060595-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pfizer
TERRAMYCIN
lidocaine hydrochloride; oxytetracycline
INJECTABLE;INJECTION060567-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Citi
Moodys
Medtronic
Novartis
Cipla
Boehringer Ingelheim
Healthtrust
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot